Harmony Gold Mining Company Ltd (HMY)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 26,600.00 |
|---|---|
| 52-week range | 19,360.00 – 39,280.00 |
| Return, 1 month / 3 months | −16.5% / +6.6% |
| Return, 1 year / 3 years | −7.2% / +433.9% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 60.7% |
| Worst drawdown (1 year) | -49.0% |
| Average daily value traded | 294.37M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Harmony Gold Mining Company is a gold producer based in South Africa. It runs underground and surface mining and processing operations that extract gold ore, and it also produces related by-products from its ore bodies. Its mines and processing plants are located in South Africa and in Papua New Guinea, and its output is refined and sold into international precious metals markets. The company supplies gold to refiners and bullion markets rather than to retail customers.
Harmony Gold Mining Company Ltd trades under the code HMY on the Buenos Aires Exchange in Argentina, with its price quoted in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Harmony Gold Mining Company Ltd (HMY) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 26,600.00 on 22 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 101 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.2% and over the last three months it rose 6.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.9% | ||
| From 52-week high | -31.1% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.6% | ||
| 6-month return | 5.7% | ||
| 12-month return, skipping the last month | 11.1% | ||
| Stability (higher is calmer) | 13 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 60.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.0% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 294.37M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −3.1% |
|---|---|
| 1 month | −16.5% |
| 3 months | +6.6% |
| 6 months | +5.7% |
| 1 year | −7.2% |
| 3 years | +433.9% |
| 5 years | +3,314.6% |
Signals
| 50-day / 200-day average | 30,638.36 / 27,678.93 |
|---|---|
| Golden / death cross (60 days) | Golden, 33 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,030.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Oct 2022 | ZAR 1.8424 |
| 7 Apr 2022 | ZAR 3.0664 |
| 14 Oct 2021 | ZAR 1.8229 |
| 15 Apr 2021 | ZAR 7.1396 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.